Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenytoin--valproic acid interaction in rhesus monkey.

K M Koch, B T Ludwick, R H Levy

    Epilepsia
    |February 1, 1981
    PubMed
    Summary

    Valproic acid (VPA) increases free phenytoin (PHT) levels in rhesus monkeys by displacing protein binding and inhibiting PHT metabolism. This drug interaction requires careful consideration during co-administration.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Quantitative Susceptibility Mapping after Sports-Related Concussion.

    AJNR. American journal of neuroradiology·2018
    Same author

    Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2013
    Same author

    An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for human epidermal growth factor receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer.

    European journal of cancer (Oxford, England : 1990)·2012
    Same author

    Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy.

    Neurology·2012
    Same author

    Are circulating metabolites important in drug-drug interactions?: Quantitative analysis of risk prediction and inhibitory potency.

    Clinical pharmacology and therapeutics·2010
    Same author

    Imaging near metal with a MAVRIC-SEMAC hybrid.

    Magnetic resonance in medicine·2010

    Area of Science:

    • Pharmacology
    • Neuroscience
    • Drug Metabolism

    Background:

    • Phenytoin (PHT) and valproic acid (VPA) are commonly prescribed antiepileptic drugs.
    • Understanding drug interactions is crucial for optimizing patient outcomes and safety.

    Purpose of the Study:

    • To investigate the pharmacokinetic interaction between PHT and VPA in a rhesus monkey model.
    • To elucidate the mechanisms underlying the observed PHT-VPA interaction.

    Main Methods:

    • Rhesus monkeys received multiple intravenous PHT boluses to achieve steady-state levels.
    • VPA was administered via successive infusions while PHT administration continued.
    • Plasma concentrations of total PHT, free PHT, and total VPA were measured.
    • In vitro studies were conducted to assess protein binding displacement.

    Main Results:

    • VPA administration did not alter total PHT plasma levels.
    • VPA significantly increased the free fraction of PHT by approximately 50%.
    • The overall elimination rate constant for PHT decreased, indicating reduced clearance.
    • In vitro results confirmed VPA's effect on PHT protein binding.

    Conclusions:

    • VPA interacts with PHT through a dual mechanism: displacement from plasma protein binding sites and inhibition of PHT metabolism.
    • These interactions lead to increased free PHT levels, potentially altering its efficacy and toxicity.
    • The findings highlight the importance of monitoring PHT levels when co-administered with VPA.

    Related Experiment Videos